OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity pharmacotherapy: incretin action in the central nervous system
Geke Aline Boer, Debbie L. Hay, Alexander Tups
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 50-63
Closed Access | Times Cited: 22

Showing 22 citing articles:

The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities
Thomas A. Wadden, Ariana M. Chao, Molly Moore, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 4, pp. 453-473
Open Access | Times Cited: 56

Are glucagon-like peptide-1 receptor agonists anti-consummatory drugs?
Rodrigo B. Mansur, Joshua D. Di Vincenzo, Sebastian Badulescu, et al.
CNS Spectrums (2025), pp. 1-6
Closed Access | Times Cited: 1

Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment
Kallirhoe Kalinderi, Vasiliki Goula, Evdoxia Sapountzi, et al.
Children (2024) Vol. 11, Iss. 2, pp. 153-153
Open Access | Times Cited: 5

Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Jang Won Son, Soo Lim
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 206-221
Open Access | Times Cited: 5

Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access

Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice
Ailin Zhang, Qinhui Liu, Yimin Xiong, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
Weijie Xie, Yuan Li, Xinyue Wang, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access

Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus
Toru Suzuki, Tatsuya Sato, Marenao Tanaka, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 7, pp. 108779-108779
Open Access | Times Cited: 3

Progress in the contrary effects of glucagon-like peptide-1 and chemerin on obesity development
Qilong Zhang, Jianping Ye, Xiaohui Wang
Experimental Biology and Medicine (2023)
Open Access | Times Cited: 4

BE-WEL trial (breast: evaluation of weight and exercise for lymphoedema) testing weight control and exercise programmes for women with breast cancer related lymphoedema: a feasibility trial
Michelle Harvie, Karen Livingstone, Debbie McMulllan, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 1, pp. 203-212
Open Access | Times Cited: 1

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Michał Nicze, Adrianna Dec, Maciej Borówka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8202-8202
Open Access | Times Cited: 1

An acidic polysaccharide promoting GLP-1 secretion from Dendrobium huoshanense protocorm-like bodies: Structure validation and activity exploration
Zhen-Zi Shang, Hui-Yu Ye, Xin Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134783-134783
Closed Access | Times Cited: 1

Novel therapeutics in rare genetic obesities: A narrative review
Béatrice Dubern, Nathan Faccioli, Christine Poitou, et al.
Pharmacological Research (2023) Vol. 191, pp. 106763-106763
Open Access | Times Cited: 3

GLP-1 analogs: a comparison of new anti diabetic medications - presenting benefits and risks
Marika Dębik, Łukasz Szydłowski, Klaudia Żurowska, et al.
Journal of Education Health and Sport (2024) Vol. 62, pp. 217-239
Open Access

Gastric bypass elicits persistent gut adaptation and unique diabetes remission‐related metabolic gene regulation
Margaret A. Stefater‐Richards, Courtney Panciotti, Valerie Esteva, et al.
Obesity (2024) Vol. 32, Iss. 11, pp. 2135-2148
Open Access

Novel 2,5-Diazabicyclo[4.2.0]octanes as GLP-1 Receptor Modulators for Treating Type 2 Diabetes
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 709-710
Open Access | Times Cited: 1

Adipocyte G Protein–Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs
Liu Liu, Jürgen Wess
Diabetes (2023) Vol. 72, Iss. 7, pp. 825-834
Closed Access | Times Cited: 1

Editorial: Incretin agonists in the treatment of obesity
Xiaodong Sun, Miaofen G. Hu, Lixin Li
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1

Sindrome dell’ovaio policistico: ruolo del glucagon-like peptide 1 (GLP-1) nella regolazione dell’asse ipotalamo-ipofisi-ovaio
Gabriella Pugliese, Giulia de Alteriis, Silvia Savastano
L Endocrinologo (2023) Vol. 24, Iss. 5, pp. 526-532
Open Access

Page 1

Scroll to top